Duke terminates patent license with Cryo-Cell effective May 17; Cryo-Cell previously sought arbitration

CRYO CELL INTERNATIONAL INC

Duke University terminated Patent and Technology License Agreement effective May 17, 2025, claiming Cryo-Cell breached.
Cryo-Cell had previously filed a demand for arbitration against Duke, alleging fraudulent inducement and breach.
The license granted Cryo-Cell exclusive rights to commercialize certain products and processes for human disease treatment.
Termination could impact Cryo-Cell's ability to commercialize the licensed technology; arbitration is ongoing.

item 1.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.